Skip to main content
. 2005 Jul 27;9(5):R502–R507. doi: 10.1186/cc3778

Figure 2.

Figure 2

28-Day all-cause mortality for PROWESS patients. Infusion refers to infusion period plus 1 calendar day after termination of infusion. DrotAA, drotrecogin alfa (activated); PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.